CELUW vs WAT · rev $54.2M vs P/E 32, rev $3.17B
Celularity Inc (CELUW) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Celularity Inc (CELUW) common stock listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
CELUW currently screens at market cap $0. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the CELUW and WAT stock pages for the full models.
Not investment advice.